Literature DB >> 21922528

Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation.

Romee Rizwan1, John E Levine, Todd Defor, James L M Ferarra, Daniel J Weisdorf, Bruce R Blazar, Michael R Verneris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21922528      PMCID： PMC3446845          DOI： 10.1002/ajh.22136

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  30 in total

1.  Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation.

Authors:  Dong Hwan Kim; Jong Gwang Kim; Sang Kyun Sohn; Woo Jin Sung; Jang Soo Suh; Kun Soo Lee; Kyu Bo Lee
Journal:  Br J Haematol       Date:  2004-04       Impact factor: 6.998

2.  Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.

Authors:  S Kumar; M G Chen; D A Gastineau; M A Gertz; D J Inwards; M Q Lacy; A Tefferi; M R Litzow
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483

Review 3.  Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.

Authors:  Ruth Seggewiss; Hermann Einsele
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

4.  Regulation of thymic epithelium by keratinocyte growth factor.

Authors:  Matthew Erickson; Stanislaw Morkowski; Sophie Lehar; Geoffrey Gillard; Courtney Beers; James Dooley; Jeffrey S Rubin; Alexander Rudensky; Andrew G Farr
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

Authors:  Ronjon Chakraverty; Guillermo Orti; Michael Roughton; Jun Shen; Adele Fielding; Panagiotis Kottaridis; Donald Milligan; Matthew Collin; Charles Crawley; Peter Johnson; Andrew Clark; Anne Parker; Adrian Bloor; Ruth Pettengell; John Snowden; Andrew Pettitt; Richard Clark; Geoff Hale; Karl Peggs; Kirsty Thomson; Emma Morris; Stephen Mackinnon
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

6.  Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation.

Authors:  Dullei Min; Patricia A Taylor; Angela Panoskaltsis-Mortari; Brile Chung; Dimitry M Danilenko; Catherine Farrell; David L Lacey; Bruce R Blazar; Kenneth I Weinberg
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

7.  Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution.

Authors:  D C Douek; R A Vescio; M R Betts; J M Brenchley; B J Hill; L Zhang; J R Berenson; R H Collins; R A Koup
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

8.  Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.

Authors:  S Kumar; M G Chen; D A Gastineau; M A Gertz; D J Inwards; M Q Lacy; A Tefferi; M R Litzow
Journal:  Leukemia       Date:  2003-09       Impact factor: 11.528

9.  Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease.

Authors:  Simona Rossi; Bruce R Blazar; Catherine L Farrell; Dimitry M Danilenko; David L Lacey; Kenneth I Weinberg; Werner Krenger; Georg A Holländer
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Authors:  Heather G Shilling; Karina L McQueen; Nathalie W Cheng; Judith A Shizuru; Robert S Negrin; Peter Parham
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113
View more
  9 in total

1.  A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Authors:  Jeffrey M Jacobson; Hongying Wang; Rebeka Bordi; Lu Zheng; Barry H Gross; Alan L Landay; John Spritzler; Jean-Pierre Routy; Constance Benson; Judith Aberg; Pablo Tebas; David W Haas; Jennifer Tiu; Kristine Coughlin; Lynette Purdue; Rafick-Pierre Sekaly
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

Review 2.  The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.

Authors:  Ioannis Politikos; Vassiliki A Boussiotis
Journal:  Blood       Date:  2014-10-06       Impact factor: 22.113

Review 3.  Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  Clin Dev Immunol       Date:  2012-03-14

Review 4.  Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Authors:  Robert Danby; Vanderson Rocha
Journal:  Front Immunol       Date:  2014-02-24       Impact factor: 7.561

Review 5.  Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.

Authors:  Saroj Vadhan-Raj; Jenna D Goldberg; Miguel-Angel Perales; Dietmar P Berger; Marcel R M van den Brink
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

6.  Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Authors:  Alasdair J Coles; Laura Azzopardi; Onajite Kousin-Ezewu; Harpreet Kaur Mullay; Sara Aj Thompson; Lorna Jarvis; Jessica Davies; Sarah Howlett; Daniel Rainbow; Judith Babar; Timothy J Sadler; J William L Brown; Edward Needham; Karen May; Zoya G Georgieva; Adam E Handel; Stefano Maio; Mary Deadman; Ioanna Rota; Georg Holländer; Sarah Dawson; David Jayne; Ruth Seggewiss-Bernhardt; Daniel C Douek; John D Isaacs; Joanne L Jones
Journal:  JCI Insight       Date:  2019-05-07

Review 7.  Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy.

Authors:  Antonella Cardinale; Carmen Dolores De Luca; Franco Locatelli; Enrico Velardi
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

Review 8.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

Review 9.  T cell regeneration after immunological injury.

Authors:  Enrico Velardi; Jennifer J Tsai; Marcel R M van den Brink
Journal:  Nat Rev Immunol       Date:  2020-10-23       Impact factor: 53.106
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.